v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net cash used in operating activities $ (41,297) $ (32,373)
Cash flows from investing activities:    
Purchases of property and equipment (639) (681)
Net cash used in investing activities (639) (681)
Cash flows from financing activities:    
Merger and PIPE financing, net of transaction costs 0 15,874
Proceeds from issuance of common stock in public offering, net of expenses 32,825 0
Additional expenses of issuance of stock in public offering (239) 0
Payment of deferred offering costs 0 (4,332)
Repurchase of shares to satisfy employee tax withholdings (47) 0
Proceeds from exercise of stock options 447 0
Repayment of advances from related party (357) (114)
Cash provided by (used in) financing activities 32,629 11,428
Effect of exchange rate changes on cash, cash equivalents and restricted cash 369 0
Net change in cash, cash equivalents and restricted cash (8,938) (21,626)
Cash, cash equivalents and restricted cash at beginning of period 46,050 50,488
Cash, cash equivalents and restricted cash at end of period 37,112 28,862
Components of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 36,847 28,588
Restricted cash (included within other assets) 265 274
Total cash, cash equivalents and restricted cash 37,112 28,862
Supplemental non-cash disclosures:    
Conversion of Legacy Blaize convertible notes to common stock 0 314,334
Net exercise of Legacy Blaize warrants for common stock 0 75,056
Issuance of warrants for professional services 0 167
Issuance of common stock for shareholder note receivable 0 8,753
Operating lease asset obtained in exchange for new operating lease liabilities 229 0
Release of liabilities to Sponsor 4,180 0
Liability to issue shares of common stock in related party settlement 2,760 0
Non-cash warrant modification expense 1,969 0
Capitalized deferred offering costs included in accounts payable and accrued expenses and other liabilities 0 380
Redemption of common shares with cash held in escrow $ 0 $ 33,157